RETATRUTIDE
Price range: $99.00 through $159.00
AUDBuy RETATRUTIDE Australia
A synthetic triple-receptor agonist peptide developed for research into coordinated GLP-1, GIP and glucagon receptor signalling and integrated metabolic pathways.
Out of Stock
RESEARCH USE ONLY
AMINOSPX products are supplied exclusively for legitimate laboratory, analytical, scientific and in vitro research purposes and are not intended for human or animal consumption.
Overview
Retatrutide is a next-generation synthetic peptide engineered as a triple receptor agonist, designed as a research model for investigating coordinated GLP-1, GIP and glucagon receptor signalling within a single molecular framework.
By integrating three complementary metabolic receptor systems into one engineered peptide, Retatrutide provides researchers with a unique model for exploring receptor cross-talk, endocrine communication and multi-target peptide design.
AMINOSPX supplies Retatrutide exclusively for legitimate laboratory, analytical, scientific and in vitro research purposes.
Not intended for human consumption or for medical, therapeutic, diagnostic, veterinary, cosmetic or food use.
Molecular Profile
- Molecular Name
- Retatrutide
- Chemical Classification
- Synthetic Triple Receptor Agonist Peptide (GLP-1 / GIP / Glucagon)
- Molecular Formula
- C221H342N46O68
- Molecular Weight
- 4731.4 g/mol (approx.)
- Length
- 39 Amino Acids
- CAS
- 2381089-83-2
- PubChem CID
- 167355980
- Form
- Lyophilised Powder
- Color
- White
- Purity
- >99% (HPLC)
- Verification
- Third-Party Laboratory Tested
- Packaging
- Sterile Vial
Research Applications
Retatrutide is studied in laboratory and in-vitro research across several areas of scientific interest, including:
GLP-1 Receptor Signalling
Used to investigate GLP-1 receptor activation within a multi-receptor experimental model.
GIP Receptor Signalling
Studied in laboratory models examining GIP receptor-mediated signalling.
Glucagon Receptor Signalling
Used to investigate glucagon-receptor pathways alongside incretin-receptor signalling.
Multi-Receptor Signalling Research
Provides an experimental model for coordinated GLP-1, GIP and glucagon receptor activation.
Research Disclaimer
Information provided on this page is supplied solely for laboratory, analytical, scientific and in vitro research purposes. Products are not intended for human or veterinary use, and the information provided does not constitute medical, pharmaceutical, healthcare or other professional advice.
Nothing contained on this website should be interpreted as a recommendation regarding the diagnosis, treatment, prevention or management of any disease, condition or health outcome.
Researchers are responsible for determining the suitability of products for their intended laboratory applications and for ensuring compliance with all applicable laws, regulations and institutional requirements.
Storage & Handling
Appropriate storage and laboratory handling help maintain product integrity and research consistency.
Storage Recommendations
- Store the lyophilised compound sealed and dry below 25°C.
- Once reconstituted, store at 2–8°C in accordance with the applicable laboratory research protocol.
- Minimise repeated freeze-thaw cycles.
- Protect from heat, moisture and direct light.
Handling Recommendations
- Use appropriate laboratory personal protective equipment (PPE).
- Follow recognised laboratory procedures appropriate to the intended research application.
- Avoid contact with eyes or skin, and avoid inhalation or ingestion.
- Maintain appropriate product identification and laboratory documentation.
- Dispose of unused material according to institutional procedures and applicable regulations.
Certificate of Analysis (COA)
Important Information
Certificates of Analysis are obtained through independent third-party analytical laboratories and provided for research and informational purposes only.
Compounds tested are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications.
Results should be interpreted by qualified professionals within the scope of the intended research and should not be considered a guarantee of suitability for any particular application.
Frequently Asked Questions
What is Retatrutide?
Retatrutide is a synthetic 39-amino-acid peptide engineered to interact with three distinct receptor systems: GLP-1, GIP and glucagon receptors. This triple-receptor design provides researchers with a defined model for investigating how multiple metabolic signalling pathways interact within a single molecular system.
What strengths of Retatrutide are available?
Aminospx Retatrutide is available in 10 mg and 20 mg variants. Select the required strength from the product options before adding the product to your cart.
What research areas is Retatrutide associated with?
Retatrutide provides researchers with a model for examining coordinated signalling across GLP-1, GIP and glucagon receptor pathways. Its multi-receptor design allows receptor cross-talk and integrated metabolic signalling to be investigated within the same experimental system.
How should Retatrutide be stored?
The lyophilised material should be stored in a sealed, dry environment below 25°C. Where laboratory reconstitution is undertaken, store reconstituted material at 2–8°C. Avoid freeze–thaw cycles to help preserve product integrity.
Customer Reviews
Be the first to leave a review
Share your experience with this product and help other researchers make informed decisions.
Share your experience with this product.
